The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4

Joo Y. Lee, Clifford A. Lowell, Danielle G. Lemay, Hyung S. Youn, Sang H. Rhee, Kyung H. Sohn, Byeong Jang, Jianping Ye, Jin H. Chung, Daniel H. Hwang

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Bacterial lipopolysaccharide (LPS) activates Toll-like receptor 4 (TLR4) leading to the expression of inflammatory gene products. Src-family tyrosine kinases (STKs) are known to be activated by LPS in monocytes/macrophages. Therefore, we determined the role of STKs in TLR4 signaling pathways and target gene expression in macrophages. The activation of NFκB, and p38 MAPK, and the expression of inducible nitric oxide synthase (iNOS) induced by LPS were not affected in macrophages deficient in three STKs (Lyn, Hck, and Fgr). These results suggest that the deletion of the three STKs among possibly nine STKs is not sufficient to abolish total activity of STKs possibly due to the functional redundancy of other STKs present in macrophages. However, two structurally unrelated pan-inhibitors of STKs, PP1 and SU6656, suppressed LPS-induced iNOS expression in MyD88-knockout as well as wild-type macrophages. The suppression of iNOS expression by the inhibitors was correlated with the downregulation of IFNβ (a MyD88-independent gene) expression and subsequent decrease in STAT1 phosphorylation. Moreover, PP1 suppressed the expression of IFNβ and iNOS induced by TRIF, a MyD88-independent adaptor of TLR4. PP1 suppressed STAT1 phosphorylation induced by LPS, but not by IFNβ suggesting that STKs are involved in the primary downstream signaling pathways of TLR4, but not the secondary signaling pathways downstream of IFNβ receptor. Together, these results demonstrate that STKs play a positive regulatory role in TLR4-mediated iNOS expression in a MyD88-independent (TRIF-dependent) manner. These results provide new insight in understanding the role of STKs in TLR4 signaling pathways and inflammatory target gene expression.

Original languageEnglish (US)
Pages (from-to)1231-1240
Number of pages10
JournalBiochemical Pharmacology
Volume70
Issue number8
DOIs
StatePublished - Oct 15 2005

Fingerprint

Toll-Like Receptor 4
src-Family Kinases
Nitric Oxide Synthase Type II
Macrophages
Lipopolysaccharides
Gene expression
Gene Expression
Phosphorylation
p38 Mitogen-Activated Protein Kinases
Redundancy
Monocytes
Down-Regulation
Genes
Chemical activation

Keywords

  • IFN-beta
  • Lipopolysaccharide
  • Nitric oxide synthase
  • Src-family tyrosine kinases
  • Toll-like receptor
  • TRIF

ASJC Scopus subject areas

  • Pharmacology

Cite this

The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. / Lee, Joo Y.; Lowell, Clifford A.; Lemay, Danielle G.; Youn, Hyung S.; Rhee, Sang H.; Sohn, Kyung H.; Jang, Byeong; Ye, Jianping; Chung, Jin H.; Hwang, Daniel H.

In: Biochemical Pharmacology, Vol. 70, No. 8, 15.10.2005, p. 1231-1240.

Research output: Contribution to journalArticle

Lee, Joo Y. ; Lowell, Clifford A. ; Lemay, Danielle G. ; Youn, Hyung S. ; Rhee, Sang H. ; Sohn, Kyung H. ; Jang, Byeong ; Ye, Jianping ; Chung, Jin H. ; Hwang, Daniel H. / The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. In: Biochemical Pharmacology. 2005 ; Vol. 70, No. 8. pp. 1231-1240.
@article{a20fe18c45484051920dcad06df04063,
title = "The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4",
abstract = "Bacterial lipopolysaccharide (LPS) activates Toll-like receptor 4 (TLR4) leading to the expression of inflammatory gene products. Src-family tyrosine kinases (STKs) are known to be activated by LPS in monocytes/macrophages. Therefore, we determined the role of STKs in TLR4 signaling pathways and target gene expression in macrophages. The activation of NFκB, and p38 MAPK, and the expression of inducible nitric oxide synthase (iNOS) induced by LPS were not affected in macrophages deficient in three STKs (Lyn, Hck, and Fgr). These results suggest that the deletion of the three STKs among possibly nine STKs is not sufficient to abolish total activity of STKs possibly due to the functional redundancy of other STKs present in macrophages. However, two structurally unrelated pan-inhibitors of STKs, PP1 and SU6656, suppressed LPS-induced iNOS expression in MyD88-knockout as well as wild-type macrophages. The suppression of iNOS expression by the inhibitors was correlated with the downregulation of IFNβ (a MyD88-independent gene) expression and subsequent decrease in STAT1 phosphorylation. Moreover, PP1 suppressed the expression of IFNβ and iNOS induced by TRIF, a MyD88-independent adaptor of TLR4. PP1 suppressed STAT1 phosphorylation induced by LPS, but not by IFNβ suggesting that STKs are involved in the primary downstream signaling pathways of TLR4, but not the secondary signaling pathways downstream of IFNβ receptor. Together, these results demonstrate that STKs play a positive regulatory role in TLR4-mediated iNOS expression in a MyD88-independent (TRIF-dependent) manner. These results provide new insight in understanding the role of STKs in TLR4 signaling pathways and inflammatory target gene expression.",
keywords = "IFN-beta, Lipopolysaccharide, Nitric oxide synthase, Src-family tyrosine kinases, Toll-like receptor, TRIF",
author = "Lee, {Joo Y.} and Lowell, {Clifford A.} and Lemay, {Danielle G.} and Youn, {Hyung S.} and Rhee, {Sang H.} and Sohn, {Kyung H.} and Byeong Jang and Jianping Ye and Chung, {Jin H.} and Hwang, {Daniel H.}",
year = "2005",
month = "10",
day = "15",
doi = "10.1016/j.bcp.2005.07.020",
language = "English (US)",
volume = "70",
pages = "1231--1240",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4

AU - Lee, Joo Y.

AU - Lowell, Clifford A.

AU - Lemay, Danielle G.

AU - Youn, Hyung S.

AU - Rhee, Sang H.

AU - Sohn, Kyung H.

AU - Jang, Byeong

AU - Ye, Jianping

AU - Chung, Jin H.

AU - Hwang, Daniel H.

PY - 2005/10/15

Y1 - 2005/10/15

N2 - Bacterial lipopolysaccharide (LPS) activates Toll-like receptor 4 (TLR4) leading to the expression of inflammatory gene products. Src-family tyrosine kinases (STKs) are known to be activated by LPS in monocytes/macrophages. Therefore, we determined the role of STKs in TLR4 signaling pathways and target gene expression in macrophages. The activation of NFκB, and p38 MAPK, and the expression of inducible nitric oxide synthase (iNOS) induced by LPS were not affected in macrophages deficient in three STKs (Lyn, Hck, and Fgr). These results suggest that the deletion of the three STKs among possibly nine STKs is not sufficient to abolish total activity of STKs possibly due to the functional redundancy of other STKs present in macrophages. However, two structurally unrelated pan-inhibitors of STKs, PP1 and SU6656, suppressed LPS-induced iNOS expression in MyD88-knockout as well as wild-type macrophages. The suppression of iNOS expression by the inhibitors was correlated with the downregulation of IFNβ (a MyD88-independent gene) expression and subsequent decrease in STAT1 phosphorylation. Moreover, PP1 suppressed the expression of IFNβ and iNOS induced by TRIF, a MyD88-independent adaptor of TLR4. PP1 suppressed STAT1 phosphorylation induced by LPS, but not by IFNβ suggesting that STKs are involved in the primary downstream signaling pathways of TLR4, but not the secondary signaling pathways downstream of IFNβ receptor. Together, these results demonstrate that STKs play a positive regulatory role in TLR4-mediated iNOS expression in a MyD88-independent (TRIF-dependent) manner. These results provide new insight in understanding the role of STKs in TLR4 signaling pathways and inflammatory target gene expression.

AB - Bacterial lipopolysaccharide (LPS) activates Toll-like receptor 4 (TLR4) leading to the expression of inflammatory gene products. Src-family tyrosine kinases (STKs) are known to be activated by LPS in monocytes/macrophages. Therefore, we determined the role of STKs in TLR4 signaling pathways and target gene expression in macrophages. The activation of NFκB, and p38 MAPK, and the expression of inducible nitric oxide synthase (iNOS) induced by LPS were not affected in macrophages deficient in three STKs (Lyn, Hck, and Fgr). These results suggest that the deletion of the three STKs among possibly nine STKs is not sufficient to abolish total activity of STKs possibly due to the functional redundancy of other STKs present in macrophages. However, two structurally unrelated pan-inhibitors of STKs, PP1 and SU6656, suppressed LPS-induced iNOS expression in MyD88-knockout as well as wild-type macrophages. The suppression of iNOS expression by the inhibitors was correlated with the downregulation of IFNβ (a MyD88-independent gene) expression and subsequent decrease in STAT1 phosphorylation. Moreover, PP1 suppressed the expression of IFNβ and iNOS induced by TRIF, a MyD88-independent adaptor of TLR4. PP1 suppressed STAT1 phosphorylation induced by LPS, but not by IFNβ suggesting that STKs are involved in the primary downstream signaling pathways of TLR4, but not the secondary signaling pathways downstream of IFNβ receptor. Together, these results demonstrate that STKs play a positive regulatory role in TLR4-mediated iNOS expression in a MyD88-independent (TRIF-dependent) manner. These results provide new insight in understanding the role of STKs in TLR4 signaling pathways and inflammatory target gene expression.

KW - IFN-beta

KW - Lipopolysaccharide

KW - Nitric oxide synthase

KW - Src-family tyrosine kinases

KW - Toll-like receptor

KW - TRIF

UR - http://www.scopus.com/inward/record.url?scp=24944549093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944549093&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2005.07.020

DO - 10.1016/j.bcp.2005.07.020

M3 - Article

VL - 70

SP - 1231

EP - 1240

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -